IPO registrations (S-1, F-1) · Registrants
BetterLife Pharma Inc.
- SEC CIK
- 1464165 · filings on EDGAR ↗
- Name on the registration
- Neurokine Pharmaceuticals Inc.
- Former names
- Pivot Pharmaceuticals Inc. (2015–2019); Neurokine Pharmaceuticals Inc. (2009–2015)
- Registration
- Form S-1, first filed 2009-08-07, last 2010-03-16; 1 initial registration, 3 amendments
- Outcome
- Declared effective 2010-03-18
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- A1
- Business address
- 1275 WEST 6TH AVENUE, Vancouver, A1 V6H 1A6
- Ticker
- BETRF (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- BetterLife Pharma Inc. on the corporate pages
Offering terms
- Shares offered
- 52,200
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Pivot Pharmaceuticals Inc. EXACT (CIK (EXACT))
- SEC filer: Neurokine Pharmaceuticals Inc. EXACT (CIK (EXACT))
Filings 5
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2009-08-07 | S-1 | S-1 (registration) | Neurokine Pharmaceuticals Inc. | 0001415408-09-000329 ↗ |
| 2009-12-03 | S-1/A | S-1/A (amendment) | Neurokine Pharmaceuticals Inc. | 0001415408-09-000540 ↗ |
| 2010-03-04 | S-1/A | S-1/A (amendment) | Neurokine Pharmaceuticals Inc. | 0001415408-10-000078 ↗ |
| 2010-03-16 | S-1/A | S-1/A (amendment) | Neurokine Pharmaceuticals Inc. | 0001415408-10-000097 ↗ |
| 2010-03-18 | EFFECT | EFFECT (declared effective) | Neurokine Pharmaceuticals Inc. | 9999999995-10-000764 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2010-03-16 | S-1/A | registration statement | 52,200 | - | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Salari Hassan | Director,TenPercentOwner | 1 | 2010 | ||
| BORMANN-KENNEDY BARBARA-JEAN ANNE | Director,Officer | President | 1 | 2015 | |
| ONG MOIRA | Officer | Chief Financial Officer | 1 | 2015 | |
| Doroudian Ahmad | Director,Officer | Chairman | 3 | 2015 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2015-12-08 | Pivot Pharmaceuticals Inc. | Pharmaceuticals | $4,227,500 | $4,227,500 | 9 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Pivot Pharmaceuticals Inc. | Form D private offerings | CIK (EXACT) | |
| SEC filer | Neurokine Pharmaceuticals Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, A1 first:
- ONCOGENEX TECHNOLOGIES INC A1
- Aspreva Pharmaceuticals CORP A1
- Lexaria Bioscience Corp. A1
- Zymeworks BC Inc. A1
- ABATTIS BIOCEUTICALS CORP A1
- BriaCell Therapeutics Corp. A1
- Old API Wind-down Ltd. A1
- AbCellera Biologics Inc. A1
- BODY & MIND INC. A1
- XORTX Therapeutics Inc. A1
In other datasets, the same topic (Health) in A1:
- Form D issuer: 1219014 B.C. Ltd. (Form D private offerings)
Interests: Pharmaceutical Preparations · Health